Tübingen, Germany

Martin Kunze

This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignees: Curevac Manufacturing Gmbh, Tesla Automation Gmbh. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Kunze. Retrieved from https://idiyas.com/inventor/martin-kunze-n4vf8f6j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martin Kunze: Innovator in RNA In Vitro Transcription

Introduction

Martin Kunze is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of RNA in vitro transcription. His innovative work has led to the development of a unique bioreactor designed for efficient RNA production.

Latest Patents

Martin Kunze holds a patent for a "Bioreactor for RNA in vitro transcription." This invention encompasses a bioreactor specifically designed for RNA in vitro transcription, a method for conducting this transcription, and an automated apparatus for RNA manufacturing. The bioreactor operates under GMP-compliant conditions, allowing for the repetitive use of DNA templates in various RNA transcription reactions. This advancement is crucial for enhancing the efficiency and reliability of RNA production processes.

Career Highlights

Throughout his career, Martin Kunze has worked with several prominent companies, including Curevac Manufacturing GmbH and Tesla Automation GmbH. His experience in these organizations has contributed to his expertise in biotechnological innovations and automated systems for RNA production.

Collaborations

Martin has collaborated with notable professionals in his field, including Benyamin Yazdan Panah and Tilmann Roos. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Martin Kunze's contributions to RNA in vitro transcription through his innovative bioreactor exemplify the importance of advancements in biotechnology. His work not only enhances RNA production but also paves the way for future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…